Výsledky vyhledávání - "Aravinda Prasad"

Akademický článek

A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia

Autor: Haridas Upadya, S. Prabhu, Aravinda Prasad, Deepa Subramanian, Swati Gupta, Ajay Goel

Publikováno v: BMC Complementary and Alternative Medicine, Vol 19, Iss 1, Pp 1-14 (2019)

Abstract Background Dyslipidemia is one of the most frequently implicated risk factors for development of atherosclerosis. This study evaluated the efficacy of amla (Emblica officinalis) extract (composed of polyphenols, triterpenoids, oils etc. as f

Externí odkaz: https://doaj.org/article/20fccd4ac4e746e3bb9f51fbf59b6d88

Zobrazit plný text záznamu

Radiant: efficient page table management for tiered memory systems

Autor: Smruti R. Sarangi, Sreenivas Subramoney, Aravinda Prasad, S. Senthil Kumar

Publikováno v: Proceedings of the 2021 ACM SIGPLAN International Symposium on Memory Management.

Modern enterprise servers are increasingly embracing tiered memory systems with a combination of low latency DRAMs and large capacity but high latency non-volatile main memories (NVMMs) such as Intel’s Optane DC PMM. Prior works have focused on the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1e4f845957446da591fc0eacb57859d3
https://doi.org/10.1145/3459898.3463907

Zobrazit plný text záznamu

Prudent Memory Reclamation in Procrastination-Based Synchronization

Autor: Aravinda Prasad, Kanchi Gopinath

Publikováno v: ASPLOS

Procrastination is the fundamental technique used in synchronization mechanisms such as Read-Copy-Update (RCU) where writers, in order to synchronize with readers, defer the freeing of an object until there are no readers referring to the object. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b9b7c6a7f5d37d295210f0d7faad1b3
https://doi.org/10.1145/2954679.2872405

Zobrazit plný text záznamu

Additional file 3: of A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia

Autor: Haridas Upadya, S. Prabhu, Aravinda Prasad, Subramanian, Deepa, Gupta, Swati, Goel, Ajay

Clinical study protocol. (PDF 343â kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0b113c52c089d96ec7ea6b2b1fd5b6d

Zobrazit plný text záznamu

Additional file 2: of A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia

Autor: Haridas Upadya, S. Prabhu, Aravinda Prasad, Subramanian, Deepa, Gupta, Swati, Goel, Ajay

Details of study sites. (DOCX 11â kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec49f1168b7ea1653de053f21c3e33b6

Zobrazit plný text záznamu

Additional file 4: of A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia

Autor: Haridas Upadya, S. Prabhu, Aravinda Prasad, Subramanian, Deepa, Gupta, Swati, Goel, Ajay

CONSORT Checklist. (DOC 219â kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68159d79bd350938ea1558dbe0761224

Zobrazit plný text záznamu

Additional file 5: of A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia

Autor: Haridas Upadya, S. Prabhu, Aravinda Prasad, Subramanian, Deepa, Gupta, Swati, Goel, Ajay

Full data of all visits. (DOCX 25â kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3db7053a5fcd87b913825baae18c752e

Zobrazit plný text záznamu

Additional file 6: of A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia

Autor: Haridas Upadya, S. Prabhu, Aravinda Prasad, Subramanian, Deepa, Gupta, Swati, Goel, Ajay

Safety parameters. (DOCX 28â kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0843be588ec041adc763e67ab5362d72

Zobrazit plný text záznamu

Additional file 1: of A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia

Autor: Haridas Upadya, S. Prabhu, Aravinda Prasad, Subramanian, Deepa, Gupta, Swati, Goel, Ajay

Characterization of amla extract. (DOC 33â kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5280af5ac8f23f6b8e4b9303785a385a

Zobrazit plný text záznamu

A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia

Autor: Swati Gupta, Ajay Goel, Haridas Upadya, Aravinda Prasad, Shruti U. Prabhu, Deepa Subramanian

Publikováno v: BMC Complementary and Alternative Medicine
BMC Complementary and Alternative Medicine, Vol 19, Iss 1, Pp 1-14 (2019)

Background Dyslipidemia is one of the most frequently implicated risk factors for development of atherosclerosis. This study evaluated the efficacy of amla (Emblica officinalis) extract (composed of polyphenols, triterpenoids, oils etc. as found in t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ba68f65c510e4c3e0699c9c95162da8
http://europepmc.org/articles/PMC6341673

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání